Table 3. NS3/4A protease inhibitors containing IFN-free combination treatment regimens and their treatment recommendations as per genotype.
adapted from EASL Recommendations on Treatment of Hepatitis C 2016 [14]
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.